Pulmozyme.com
| Top pulmozyme sites |
- Title
- Pulmozyme® (dornase alfa) Cystic Fibrosis Treatment
- Meta Description
- Find information about cystic fibrosis and Pulmozyme®, including your CF treatments and options for financial support. Indication and Usage Pulmozyme® (dornase alfa) is indicated for daily administration along with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function. In CF patients with an FVC ≥ 40% of predicted, daily administration of Pulmozyme® has also been shown to reduce the risk of respiratory tract infections requiring injectable antibiotics. Important Safety Information Pulmozyme® should not be used in patients who are allergic to any of its ingredients. Patients may experience the following when using Pulmozyme®: change in or loss of their voice, discomfort in the throat, rash, chest pain, red watery eyes, runny nose, lowering of lung function, fever, indigestion, and shortness of breath. There have been no reports of severe allergic reactions caused by the administration of Pulmozyme. Mild to moderate hives and mild skin ...
- Meta Keywords
- Technologies in use
- Google Analytics, GoogleFontApi, Drupal, jQuery
| Expires | Sun, 19 Nov 1978 05: |
| Last-Modified | Sun, 18 Feb 2018 08: |
| Cache-Control | no-cache, must-reval |
| ETag | "1518943138" |
| Content-Language | en |
| Content-Type | text/html; charset=u |
| Content-Length | 29676 |
| Accept-Ranges | bytes |
| X-Varnish | 1683771562 |
| Age | 0 |
| Connection | keep-alive |
| X-Cache | MISS |